Tecarfarin Not Yet Recruiting Phase 3 Trials for Thromboembolism / thrombotic events Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02522221Tecarfarin Anti-Coagulation Trial (TACT)